Cannabinoids in Pediatric Medicine: Research and Clinical Insights
Cannabinoids for pediatric medicine have been studied in various medical conditions, with strongest evidence for refractory epilepsy. Current research highlights safety and efficacy concerns in pediatric care. Clinicians should use updated evidence to…
Cannabinoid Clinical Trials: CBD for Fibromyalgia Pain
This randomized, double-blind, placebo-controlled trial evaluated CBD for fibromyalgia pain. Results showed CBD did not outperform placebo in reducing pain intensity. These findings highlight the need for cautious interpretation of CBD for fibromyalgia…
Endocannabinoid System Clinical Research: Eating Disorders
This article covers endocannabinoid system adolescent eating disorder research focusing on how adolescent risk factors contribute to eating disorders. The study highlights the importance of early screening for disordered eating and body image concerns.…
Clinical Research on Endocannabinoid System in Mental Health RCTs
This study examines endocannabinoid system clinical research mental health RCTs evaluating the Minder mobile app for university students. The trial tests digital tools addressing mental health and substance use challenges. Results provide clinical…
Endocannabinoid System Research: Cannabinoids for Children
Cannabinoids for pediatric care have been studied in various medical conditions with evolving evidence. The strongest data supports use in specific epilepsy syndromes. Safety and efficacy findings in other pediatric conditions remain limited and variable.
AM Policy Update: March 11, 2026 – DEA Rescheduling Marijuana
The DEA rescheduling marijuana update on March 11, 2026, marks a significant federal regulatory change. This update affects cannabis medicine by recognizing its medical potential. It highlights the evolving landscape of controlled substances and federal…
AM Study Update: March 11, 2026
This AM Study Update highlights cannabis clinical research 2026 with 20 prioritized studies from PubMed. The update covers clinical trials and systematic reviews relevant to cannabis medicine. Clinicians will find evidence-based insights for March 11,…
AM News Update: March 11, 2026
This March 11, 2026 update highlights cannabis cognitive function research and its clinical implications. Studies reveal THC's impact on memory and cannabinoids' potential for liver disease treatment. Regulatory and legal developments also shape the…
Cannabinoid Clinical Trials: PTSD and Substance Use Disorders
Clinical evidence from PTSD substance use cannabis trials shows that trauma-focused treatments remain effective for patients using cannabis. Cannabis use does not appear to undermine treatment outcomes compared to non-users. Clinicians should not delay…
Clinical Research on Minder Mobile App for Mental Health and Substance Use
This digital mental health intervention RCT tested the Minder mobile app designed for university students. The study assessed its effectiveness in improving mental health and substance use outcomes. Results provide evidence supporting scalable digital…